Navigation Links
New Vaccine To Combat The Deadly Marburg Virus

The study team involving researchers from the U.S. Army Medical Research Institute of Infectious Diseases and the National Microbiology Laboratory// at the Public Health Agency of Canada reported yesterday that the vaccine that is used to protect monkeys by in preventing hemorrhagic fever in monkeys after they were exposed to the deadly Marburg virus. Could also provide the first known treatment for the infection caused by Ebola virus.

The researchers now claim that they have created a vaccine by replacing a gene from a harmless virus with a gene encoding a surface protein on the Marburg virus. In their study, which was reported in the April 27th issue of The Lancet, the researchers infected five rhesus monkeys with the Marburg virus and then injected them with the vaccine 20 to 30 minutes later. They used three other monkeys as controls infected them with the virus but were given a vaccine without the Marburg protein. They found that all five monkeys that received the Marburg protein vaccine survived for at least 80 days, while the controls died within 12 days.

Geisbert, whose team worked with colleagues at the National Microbiology Laboratory at the Public Health Agency of Canada, said that the team were very surprised at the results but stated that it may be a while before the vaccine is tested in people but he hoped it is a first step. He said that if the vaccine was so effective in monkeys given high doses of virus, it should be effective in an outbreak scenario in which people typically get lower doses.

The Ebola virus, like the Marburg causes internal bleeding at multiple sites causing hemorrhagic fever and victims usually die of multiple organ failure and shock. Both viruses are considered to be potential bio terrorism threats. Currently there are no drugs to fight infection with Marburg virus or the Ebola, both of which are caused by a family of viruses known as filoviruses, and even treatment aimed at easing the illness and symptoms rarely work. This new study suggests the vaccine may be an effective post-infection treatment for the disease.

Marburg virus killed more than 300 people -- 90 percent of those infected -- in Angola last year. Ebola is usually somewhat less deadly and killed 254 people between 2001 and 2005 in Gabon and the Democratic Republic of Congo.
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... ... 2017 , ... Support of value-based care models requires collaboration across all facets ... industry solutions, Fogo Data Centers announces the launch of the Fogo Partner Community™. , ... one in which all systems work well, work together, and work together well. ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... of technology-enabled clinical trial solutions, today announced the further expansion of its ... applications they can leverage as part of Bioclinica’s extensive and growing eHealth ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based Jvion, ... analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, received ... giants including Accenture, GE Ventures, and Software AG , will bring top ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... chronically untreated despite the medical, mental health, and financial consequences of inaction. On ... to take action if they have concerns about their hearing. , Effective treatment ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... protein espresso drinks, announced its products are now available for purchase on RonnieColemanNutrition.com, ... Drink Mix has become popular among health-conscious consumers who love coffee but are ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and Strategies ... Cirrhosis market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Liver Cirrhosis ...
(Date:2/21/2017)... and Markets has announced the addition of the "Rosacea Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Rosacea ... market? What are the unit prices and annual treatment ...
(Date:2/21/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Anthrax Drugs Price Analysis and Strategies - 2016, provides drug ... research answers the following questions: What are the ... positioned in the Global Anthrax market? What are the ...
Breaking Medicine Technology: